HomeSNDX • NASDAQ
add
Syndax Pharmaceuticals Inc
Previous close
$19.89
Day range
$19.44 - $20.17
Year range
$11.23 - $25.34
Market cap
1.68B USD
Avg Volume
1.06M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 3.50M | — |
Operating expense | 33.38M | 79.34% |
Net income | -68.06M | -52.56% |
Net profit margin | -1.94K | — |
Earnings per share | -0.80 | -25.00% |
EBITDA | -74.21M | -49.40% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 432.27M | 6.46% |
Total assets | 476.95M | 10.57% |
Total liabilities | 42.61M | 36.14% |
Total equity | 434.34M | — |
Shares outstanding | 85.10M | — |
Price to book | 3.89 | — |
Return on assets | -36.38% | — |
Return on capital | -39.95% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -68.06M | -52.56% |
Cash from operations | -71.64M | -102.55% |
Cash from investing | 61.75M | -16.45% |
Cash from financing | 676.00K | -48.94% |
Net change in cash | -9.22M | -123.13% |
Free cash flow | -47.84M | -184.50% |
About
Founded
2005
Headquarters
Website
Employees
112